Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Rose Knapp, RN, MSN, APRN-BC Clinical Faculty NYU College of Nursing Professor of Pharmacology Acute Care Nurse Practitioner
Learning Objectives
1. Discuss the specific medication needs of the elder patient 2. Describe the variables when choosing s medication for the elder adult 3. Discuss causes and prevention of polypharmacy 4. Discuss the JCAHO recommendations and the medication reconciliation process
Statistics:
Drug use in the elderly is disproportionately high Patient over 65 constitute 12% of the population and consume 31% of prescribed drugs secondary to:
Principle factors:
Altered Pharmacokinetics Multiple and severe illness Multiple drug therapy Poor adherence
Increased gastric pH Decreased absorptive surface area Decreased gastric motility Delayed gastric emptying
Pharmacokinetic changes
Distribution of Drugs:
Increased body fat Decreased lean muscle mass Decreased serum albumin Decreased cardiac output Decreased total body water
Pharmacokinetic changes
Metabolism of Drugs
Decreased hepatic blood flow Decreased hepatic mass Decreased activity of hepatic enzymes
Pharmacokinetic changes
Excretion of Drugs:
renal blood flow glomerular filtration rate tubular secretion number of nephrons
Pharmacodynamics
Increased drug sensitivity Changes in blood-brain barrier Alteration in receptor properties Increased Adverse Drug Reactions (ADRs)
ADR are 7 times more common in the elderly Account for 16% of hospital admission and 50% of medication related deaths
Drug accumulation secondary to reduced renal function Polypharmacy Greater use of drugs with a low therapeutic index ( i.e. digoxin) Inadequate supervision of long-term therapy Poor patient adherence
Multiple chronic disorders Multiple prescribers Multiple prescriptions Multiple doses Change in daily drug regime Cognitive or physical impairment Living alone Recent Hospital discharge Inability to pay for drugs Presence of side effects
Polypharmacy
Average person over 65 takes an average of 4.5 prescription medications at a time plus 2 OTC medications
Polypharmacy
A quote from Love in the Time of Cholera by Gabriel Garcia Marquez: He rose at the crack of dawn when he began his secret medicine, bromides to raise the spirits, salicylates for the aches in his bones when it rained, ergosterol for vertigo, belladonna for sound sleep. But in his pocket he always carried a little pad of camphor that he inhaled deeply when no one was watching , to calm his fear of so many medication mixed together
Medication Appropriateness
Overuse of a Medication
Antibiotics GI Medications Sleep medications Wrong dose and/or frequency Chronic disease Preventative medications- vaccines
Misuse
Underuse
Beers Criteria
Increase nursing awareness of high-risk medications Monitoring of adverse effects Facilitates collaborative efforts of health care providers
Best Tool: HCFA Guidelines for Potentially Inappropriate Medications in the Elderly
Identifies medications that have potential risks that outweigh benefits Universally appropriate for all patients over 65 Provides a rating of severity for adverse outcomes Provides a descriptive summary associated with the education
Beers Criteria
Strengths
Developed by 6 nationally known experts in geriatric care and pharmacology Widely used to screen populations for possible drug-related problems
Does not identify all cases of potentially inappropriate prescribing Is not a substitute for professional judgment
Limitations
Medication Reconciliation
- Definition: The process of comparing a patients medication orders to all medications that the patient has been taking.
Medication Reconciliation
5 Step Process:
Develop a list of medications Develop a list of medications to be prescribed Compare the 2 lists Make clinical decision based on the comparison Communicate the new list to the appropriate caregivers and the patient
JCAHO Requirements
8a) implement a process for obtaining and documenting a complete of patient medications on admission 8b) a complete list of patient medications is communicated to the next care provider
Addendum- that a patient who is unable to participate in medication reconciliation has an authorized person involved in the process in all interfaces of care and on admission and discharge from the facility JCAHO 2/06
JCAHO Recommendations
Place medications list in a highly visible location in patient chart Create a process for reconciling medications at all interfaces of care On discharge from a facility, provide patient with the complete list of medications
Complete drug history including OTC and herbals Account for pharmacokinetic and pharmacodynamic changes that occur with aging Initiate therapy with low doses Monitor clinical response and plasma drug levels Employ simplest regime possible Monitor drug-drug interactions Periodically review drug regime Encourage patient to dispose of old medications Promote adherence to drug regime
Simplify regime Clearly explain treatment plan Choosing appropriate dosage form Label containers clearly Suggest a calendar, diary or pill counter Assure patients access to a pharmacy Assure affordability of medication Involve a family member or friend Monitor therapeutic responses, adverse reactions and plasma drug levels
Case Study
Mrs. A. is a 71 year old widow with CHF and osteoarthritis who has recently been exhibiting quite unusual behavior. Her daughter is concerned about her mother's ability to remain independent and wishes to pursue nursing home admission arrangements. She fears the development of a dementing illness. Over the last two to three months, Mrs. A. has become confused, easily fatigued and very irritable. She has developed disturbing obsessive/compulsive behavior constantly complaining that her lace curtains were dirty and required frequent washing. Detailed questioning revealed that she thought they were yellow-green and possibly moldy. Her prescribed medications are:
* Furosemide 40 mg daily in the morning * Digoxin 250 micrograms daily
* *
Acetamenophen 500 mg, 1-2 tablets 4-hourly PRN joint pain Mylanta suspension, 20 ml prn
Furosemide
Dosage Indication Adverse Effects- hypokalemia Considerations: monitor serum K, observe for signs of hypokalemia- fatigue, muscle weakness and cramping Effect on Digoxin Potassium Supplements Best time to administer medication Teach patient and family about foods high in K
Digoxin
Dosage Indication Early signs of toxicity- weakness, anorexia, GI distress Late signs of toxicity- confusion, visual color disturbances, arrhythmias, headache Relationship of K and Digoxin Obtain baseline vital signs Check digoxin and K levels Mylantas effect on digoxin
Acetaminophen
Dosage Indication Adverse reactions: severe liver damage, rash Observe for hepatic damage
Mylanta
Dosage Indications Adverse reactions: diarrhea/constipation Aluminum-constipation, Magnesium-diarrhea Magnesium based- caution with renal disease May alter absorption of many drugs Potential for adverse reaction with Digoxin
Case Study
Mrs. A is a victim of polypharmacy Digoxin dosage with digoxin toxicity Mylanta interacts with digoxin Lasix and digoxin interation
REMEMBER
References
Abrams, WB, Beers, MH. Clinical Pharmacology in an aging population. Clinical Pharmacology Therapeutics 1998:63:281-4. Beers, MH. Explicit criteria for determining potentially inappropriate medication use in the elderly. Archives of Internal Medicine 1997: 157: 15316. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-2724 ISMP Medication Safety Alert, April 21, 2005, http://www.ismp.org/MSAarticles/20050421.htm Institute for Healthcare Improvement website includes a section on Medication Reconciliation Review, including samples of a reconciliation tracking tool and a medication reconciliation flowsheet, http://www.ihi.org/ (Lehne, Richard A.. Pharmacology for Nursing Care, 6th Edition. W.B. Saunders Company, 062006. 11). J.D. Rozich, M.D., Ph.D., M.B.A., "Standardization as a Mechanism to Improve Safety in Health Care," Joint Commission Journal on Quality and Safety, Volume 30, Number 1, January 2004, pages 5-14
1.